Analysis of patent litigation, PTAB practice, prosecution and pharma IP, written on the data behind LexDana.
Tagged pharmaceuticals · clear
The Oncomouse patent stands as a remarkable milestone in the field of biotechnology patents, revolutionizing the way we approach biomedical research. This groundbreaking patent, which involved genetically modifying a mouse to be predisposed to cancer,…
Written by : Nima Zargari, Ph.D. & Joseph Mallon, Ph.D. On April 26, 2023, the European Commission proposed a pharmaceutical law reform directed to replacing the existing pharmaceutical legislation. The reform aims to increase innovation and competition in…
SANOFI-AVENTIS DEUTSCHLAND GMBH V. MYLAN PHARMACEUTICALS INC. Before Reyna, Mayer, and Cunningham . Appeal from Patent Trial and Appeal Board. Summary : When arguing that a reference is analogous prior art, a petitioner must show that the reference is…
Written by : Jeremy Anapol UNITED CANNABIS CORPORATION V. PURE HEMP COLLECTIVE INC. Before Lourie, Cunningham, and Stark . Appeal from the United States District Court for the District of Colorado. Summary : The Federal Circuit affirmed the district…
Written by : Matthew S. Whitehead & Douglas B. Wentzel UCB, INC. v. ACTAVIS LABORATORIES UT, INC. Before Moore, Chen, and Stoll . Appeal from the U.S. District Court for the District of Delaware. Summary : District court legally erred by applying incorrect…
Written by : Ari Feinstein & Agnes Juang, Ph.D. On March 29, 2023, the Solicitor General of the United States asked the Supreme Court to review a Federal Circuit judgment in a Hatch-Waxman case between Teva and GSK. In its decision below, the Federal…
Written by : Brandon D. Hupka & Hans L. Mayer REGENTS OF THE UNIVERSITY OF MINNESOTA V. GILEAD SCIENCES, INC. Before Lourie , Dyk, and Stoll. Appeal from the Patent Trial and Appeal Board. Summary : For drug patents, adequate written description of a broad…
Written by : Tyler S. Cox & Kendall Loebbaka JAZZ PHARMACEUTICALS, INC. v. AVADEL CNS PHARMACEUTICALS, LLC Before Lourie, Reyna, and Taranto. Appeal from the United States District Court for the District of Delaware. Summary: A patent directed to a system…
Written by : Kendall Loebbaka & Cesar A. Estrada GENENTECH, INC. V. SANDOZ INC. Before Newman, Lourie, and Prost. Appeal from the United States District Court for the District of Delaware. Summary: The district court did not clearly err in considering…
In late August, we published our third annual ANDA Litigation Intelligence Report. We evaluated the stakeholders for Hatch-Waxman cases filed between July 1, 2017, and June 30, 2022. This report's major highlights have been covered in our previous…
In late August, we published our third annual ANDA Litigation Intelligence Report, covering important statistics and evaluating all stakeholders in Hatch-Waxman litigation, including attorneys, local counsel, law firms, generic and brand pharmaceutical…
MYLAN PHARMACEUTICALS INC. v. MERCK SHARP & DOHME CORP. Before Lourie, Reyna and Stoll. Appeal from the Patent Trial and Appeal Board. Summary: “At once envisage” what is missing cannot fill in the gap to establish anticipation when the class…
